Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Efficacy Capital

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$21M
Portfolio companies 1
Lead investments 0
Exits 1
Key employees Soon

Areas of investment

  • Health Care
  • Therapeutics
  • Hospital
  • Biotechnology
Summary

The main office of represented VC is situated in the San Diego. The venture was found in North America in United States.

The typical case for the fund is to invest in rounds with 3 participants. Despite the Efficacy Capital, startups are often financed by Xmark Asset Management. The meaningful sponsors for the fund in investment in the same round are Xmark Opportunity Funds, OrbiMed.

Among the various public portfolio startups of the fund, we may underline Arius Research Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are Therapeutics, Hospital. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Canada.

The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in less than 2 deals every year. The top amount of exits for fund were in 2008. The high activity for fund was in 2006.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Efficacy Capital:
Typical Co-investors
Efficacy Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Efficacy Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Ange Basile -
Canadian Western Bank Alberta, Canada, Edmonton
Cross Head Japan, Tokyo
Downey Ventures Beverly Hills, California, United States
East Coast Ventures -
EGL Ventures Atlanta, Georgia, United States
F&C Asset Management England, London, United Kingdom
FCA Investments Finland, Helsinki, Southern Finland
Jinmanhui Touzi Beijing, Beijing, China
Lanhu Capital Beijing, Beijing, China
Nekko Capital Barcelona, Catalonia, Spain
Oxx England, London, United Kingdom
Riot Games California, Los Angeles, United States
Skylight Consulting Japan, Tokyo
Software AG Darmstadt, Germany, Hessen
Technorov Holdings -
Tvmining China, Jiangsu, Wuxi Shi
UDR Colorado, Highlands Ranch, United States
Wuxi Gaode Venture Capital Management Anhui, China, Wuxi
York Angels Investors Canada, Ontario, Toronto

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Arius Research

Biotechnology
Health Care
Hospital
Therapeutics
$21M01 Mar 2006 Ontario

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Efficacy Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: